Alector, Inc.
$2.36
The Read: 8% as it lost regulatory path for AL001 and discontinued the AL101 trial, removing key near-term catalysts.
ALEC
Hover to view data
No Data
By creating an account you agree to our Terms of Service and Privacy Policy.
$2.36
The Read: 8% as it lost regulatory path for AL001 and discontinued the AL101 trial, removing key near-term catalysts.
No Data